Ani Pharmaceuticals (ANIP) Payout Ratio (2021 - 2025)

Ani Pharmaceuticals has disclosed Payout Ratio across 5 years of filings, most recently posting 0.01 for Q3 2025.

• In Q3 2025, Payout Ratio rose 179.24% year-over-year to 0.01; the TTM figure through Jun 2026 stood at 0.0 (up 102.32% YoY), while the FY2025 annual figure was 0.01, up 118.59% from the prior year.
• Payout Ratio came in at 0.01 for Q3 2025 at Ani Pharmaceuticals, down from 0.05 in the prior quarter.
• In the past five years, Payout Ratio ranged from a high of 0.54 in Q4 2023 to a low of 0.15 in Q2 2024.
• Average Payout Ratio over 5 years is 0.05, with a median of 0.0 recorded in 2021.
• Year-over-year, Payout Ratio plunged 1020.62% in 2022 and jumped 2092.81% in 2023.
• Over 5 years, Payout Ratio stood at 0.01 in 2021, then sank by 1020.62% to 0.09 in 2022, then jumped by 719.3% to 0.54 in 2023, then tumbled by 107.01% to 0.04 in 2024, then soared by 134.45% to 0.01 in 2025.
• Per Business Quant data, the three most recent Payout Ratio figures were 0.01 in Q3 2025, 0.05 in Q2 2025, and 0.03 in Q1 2025.